The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Although Lilly started consistently raising its dividend in 2015, investors should be aware of some details around the schedule of these payments. Every year since then, Lilly announced a hike to its ...
The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...
Shortly after a positive data drop for Eli Lilly’s efsitora alfa, the Indianapolis-based company is again padding the case for its weekly insulin prospect. Tuesday, Lilly revealed that ...
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...
Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs ...
Share on Pinterest Eli Lilly’s once-weekly insulin injection is as effective as daily shots for managing blood sugar in diabetes, new data shows. Scott Olson/Getty Images New research offers ...
Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback